Green Silver Nanoparticle Synthesis via Larval Gut Extract

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nanoparticle synthesis methods are costly and produce harmful by-products, and green methods using plant extracts face challenges in controlled delivery and variable activities of nanoparticles.

Innovation Solution

Synthesis of Rhynchophorus ferrugineus silver nanoparticles using an aqueous larval gut extract and silver nitrate, resulting in nanoparticles with a particle size ranging from 45 nm to 90 nm, which can be used as antibacterial agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional synthesis methods (physicochemical, thermal decomposition, electrochemical, etc.) are used to produce nanoparticles, then nanoparticles can be synthesized, but the methods are costly and produce harmful by-products that pose increased risks to human health and the environment

Engineering Contradiction:
Improvesynthesis costVSAvoidharmful by-products
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful conventional synthesis methods into beneficial green chemistry approaches by using plant-based extracts (Rhynchophorus ferrugineus larval gut extract) as reducing agents. This transforms the problem of harmful by-products into a solution where natural biochemical compounds facilitate nanoparticle synthesis without toxic waste, aligning with the blessing in disguise principle of converting harmful factors into beneficial effects.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the chemical parameters of the synthesis process by replacing conventional chemical reducing agents with biological extracts containing specific biochemical compounds. This parameter change from synthetic chemicals to natural biochemical substances fundamentally alters the synthesis outcome, eliminating harmful by-products while maintaining nanoparticle production capability.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If green methods using plant extracts are used to prepare nanoparticles, then the methods are safer, faster, environmentally friendly, and economical, but the activities and characteristics of the nanoparticles vary significantly depending upon the detailed method of synthesis and specific plant extract used

Engineering Contradiction:
Improvesafety and environmental friendlinessVSAvoidnanoparticle activity consistency
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies local quality by focusing on a specific localized source (Rhynchophorus ferrugineus larval gut extract) with defined biochemical composition. This localized approach ensures consistent nanoparticle characteristics by using a standardized biological source with known chemical properties, rather than varying plant extracts, thereby improving reliability while maintaining green chemistry benefits.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs self-service by utilizing the larval gut extract's inherent biochemical compounds to automatically reduce silver ions and form nanoparticles. The biological system performs the reduction function naturally, eliminating the need for external chemical reducing agents and ensuring consistent, reproducible nanoparticle synthesis with reliable activity.

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If green methods using plant extracts are used to prepare nanoparticles, then the methods are safer, faster, environmentally friendly, and economical, but the therapeutic potential of plant extracts has been compromised due to the lack of controlled delivery of an effective dose to the desired target site

Engineering Contradiction:
Improveenvironmental friendlinessVSAvoidcontrolled delivery
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The patent extracts the active nanoparticle-forming function from the complex plant extract system and isolates it into a controlled synthesis process. By extracting the essential reducing activity from the larval gut extract and applying it specifically to silver ion reduction, the patent achieves controlled delivery of nanoparticles with effective doses, separating the beneficial nanoparticle formation from the complexity of delivering entire plant extracts.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nanoparticles effectively inhibit bacterial growth, including multi-drug resistant pathogens, and are administered through a pharmaceutical composition for targeted delivery.

Implementation Method 1

mixing an aqueous larval gut extract from Rhynchophorus ferrugineus with silver nitrate to obtain aqueous Rhynchophorus ferrugineus silver nanoparticles

Methodology Applied
Scientific EffectChemical reduction: Reduction

Implementation Method 2

drying the aqueous Rhynchophorus ferrugineus silver nanoparticles to obtain the Rhynchophorus ferrugineus silver nanoparticles

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS12121548B1Method for synthesizing a silver nanoparticle composition from Rhynchophorus ferrugineus larvae olivier
Publication Date: 2024.10.22 KING FAISAL UNIV
  • US12121548B1 patent drawing

AI summary

Rhynchophorus ferrugineus silver nanoparticles can be synthesized by mixing an aqueous larval gut extract of Rhynchophorus ferrugineus with an equal proportion of silver nitrate to provide a solution including Rhynchophorus ferrugineus silver nanoparticles. The Rhynchophorus ferrugineus silver nanoparticles can be useful as antibacterial agents.